These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 24974880)
1. Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review]. Kageyama K; Oki Y; Nigawara T; Suda T; Daimon M Endocr J; 2014; 61(10):941-8. PubMed ID: 24974880 [TBL] [Abstract][Full Text] [Related]
2. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease. Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723 [TBL] [Abstract][Full Text] [Related]
3. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas. Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314 [TBL] [Abstract][Full Text] [Related]
4. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay. Kojima Y; Suzuki S; Yamamura K; Ohhashi G; Yamamoto I Endocr J; 2002 Jun; 49(3):285-92. PubMed ID: 12201210 [TBL] [Abstract][Full Text] [Related]
5. Long-term remission of cyclic Cushing's disease that was diagnosed and treated surgically in non-active phase. Asano S; Ooka H; Okazaki R; Ishikawa T; Ochiai H; Nakashima M; Ide F; Hasegawa I; Miyawaki S; Nakaguchi H; Murakami M; Ogino Y; Takano K; Matsuno A Endocr J; 2007 Jun; 54(3):407-12. PubMed ID: 17446656 [TBL] [Abstract][Full Text] [Related]
6. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases. Zhang K; Shou X; Chen H; Qiao N; He W; Chen Z; Shen M; Li S; Zhao Y; Zhang Z; Li Y; Ye H; Wang Y Front Endocrinol (Lausanne); 2020; 11():608691. PubMed ID: 33584540 [TBL] [Abstract][Full Text] [Related]
7. Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas. Kim D; Ku CR; Park SH; Moon JH; Kim EH; Kim SH; Lee EJ World Neurosurg; 2018 Jul; 115():e464-e471. PubMed ID: 29678704 [TBL] [Abstract][Full Text] [Related]
8. Rare case of Cushing's disease due to double ACTH-producing adenomas, one located in the pituitary gland and one into the stalk. Mendola M; Dolci A; Piscopello L; Tomei G; Bauer D; Corbetta S; Ambrosi B Hormones (Athens); 2014; 13(4):574-8. PubMed ID: 25402386 [TBL] [Abstract][Full Text] [Related]
9. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule. Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905 [TBL] [Abstract][Full Text] [Related]
10. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease. Rak B; Maksymowicz M; Pękul M; Zieliński G Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861 [TBL] [Abstract][Full Text] [Related]
11. Current status on histological classification in Cushing's disease. Syro LV; Rotondo F; Cusimano MD; Di Ieva A; Horvath E; Restrepo LM; Wong M; Killinger DW; Smyth H; Kovacs K Pituitary; 2015 Apr; 18(2):217-24. PubMed ID: 25501318 [TBL] [Abstract][Full Text] [Related]
12. Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Langlois F; Lim DST; Yedinak CG; Cetas I; McCartney S; Cetas J; Dogan A; Fleseriu M Pituitary; 2018 Feb; 21(1):32-40. PubMed ID: 29032459 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of screening for subclinical Cushing's disease in patients with pituitary tumors. Tamada D; Kitamura T; Otsuki M; Oshino S; Saitoh Y; Shimomura I Endocr J; 2016; 63(1):47-52. PubMed ID: 26536898 [TBL] [Abstract][Full Text] [Related]
14. Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report. Andrioli M; Pecori Giraldi F; Losa M; Terreni M; Invitti C; Cavagnini F Endocr J; 2010; 57(9):833-7. PubMed ID: 20595779 [TBL] [Abstract][Full Text] [Related]
15. Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia. Haap M; Gallwitz B; Meyermann R; Mittelbronn M Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):289-93. PubMed ID: 19085700 [TBL] [Abstract][Full Text] [Related]
16. The role of somatostatin analogs in Cushing's disease. van der Hoek J; Lamberts SW; Hofland LJ Pituitary; 2004; 7(4):257-64. PubMed ID: 16132202 [TBL] [Abstract][Full Text] [Related]
17. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease. Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046 [TBL] [Abstract][Full Text] [Related]
18. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway. Jian F; Chen Y; Ning G; Fu W; Tang H; Chen X; Zhao Y; Zheng L; Pan S; Wang W; Bian L; Sun Q Oncotarget; 2016 Feb; 7(8):9175-87. PubMed ID: 26824322 [TBL] [Abstract][Full Text] [Related]
19. Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma. Donofrio CA; Losa M; Gemma M; Giudice L; Barzaghi LR; Mortini P Endocrine; 2017 Nov; 58(2):303-311. PubMed ID: 28005257 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors of Long-Term Remission After Surgical Treatment of Cushing's Disease. Ioachimescu AG Endocrinol Metab Clin North Am; 2018 Jun; 47(2):335-347. PubMed ID: 29754635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]